NCT01935934 2025-10-01
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
5 trialsNCT03748186 2025-08-20
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
Sutro Biopharma, Inc.
Phase 1 Completed
NCT04458597 2025-08-01
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT02093598 2020-11-27
POEM
MedSIR
Phase 2 Completed
NCT01440998 2018-04-05
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
Phase 1 Completed